# Regulation of T cell responses by P2RX7

> **NIH NIH R01** · UNIVERSITY OF MINNESOTA · 2020 · $550,688

## Abstract

Summary
One of the best defined “danger” signals, that alerts the innate immune system to cellular damage, is
extracellular ATP, triggering ion flux through the purinergic receptor P2RX7. The roles of P2RX7 in the
adaptive immune system, by contrast, are less clear. We recently showed that P2RX7 was essential for
production and maintenance of long-lived CD8+ T cell memory. This involved P2RX7 signals promoting the
establishment of mitochondrial maintenance and metabolic “fitness” in differentiating memory CD8+ T cells, but
we also found evidence that sustained P2RX7 signals are needed to sustain pre-existing memory CD8+ T
cells, suggesting this “danger” signal is repurposed to provide a homeostatic survival signal for CD8+ T cells.
Much remains to be understood about how P2RX7 signaling influences T cell memory, however. In Aim 1, we
turn our attention to CD4+ T cells: while P2RX7 is critical for generation of memory CD8+ T cells, certain
subsets of memory CD4+ T cells (including follicular helper-like central memory cells), show increased survival
when P2rx7 is ablated – we explore the basis for these differential effects of P2RX7 stimulation on CD4+ and
CD8+ memory T cell subsets. In Aim 2, we explore how memory CD8+ T cells may be able to provide autocrine
stimulation of P2RX7 through export of their “own” ATP, through the Pannexin 1 channel. Finally, P2RX7 has
been shown to play an important role in another area of biology – in chronic pain. Sustained stimulation of
P2RX7 on innate immune cells is thought to be responsible for various forms of neuropathic and inflammatory
pain (associated with nerve damage, autoimmune diseases, cancer, etc.) and pharmacological blockade of
P2RX7 has been shown in animal models to alleviate such chronic pain. This raises the key question of
whether use of such therapeutic blockade leads to degradation of pre-existing T cell memory - in particular,
whether such treatment would impair CD8+ T cell mediated control of persistent viral infections. We address
this in Aim 3, also investigating whether directed stimulation (rather than blockade) of P2RX7 can be used as a
viable way to improve the generation of long-lived CD8+ T cell memory and potentially to enhance control of
chronic viral infections but may also dysregulate the CD4+ T cell memory compartment. Together, these
studies represent a novel and highly significant investigation into how an innate immune trigger is co-opted into
regulating adaptive immune memory, and how this pathway can be harnessed for therapeutic goals with
possible application to the clinic.

## Key facts

- **NIH application ID:** 9931134
- **Project number:** 5R01AI145147-02
- **Recipient organization:** UNIVERSITY OF MINNESOTA
- **Principal Investigator:** STEPHEN C JAMESON
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $550,688
- **Award type:** 5
- **Project period:** 2019-05-17 → 2024-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9931134

## Citation

> US National Institutes of Health, RePORTER application 9931134, Regulation of T cell responses by P2RX7 (5R01AI145147-02). Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/grant/nih/9931134. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*